Watch CPMV. Know when insiders buy.
One email the day a filing lands. Free.
CPMV
Mosaic ImmunoEngineering Inc.
0.09
+0.00 +0.00%
USD · close Sep 10
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $616KP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$687KNET CASH —52W 0.05 – 1.05SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$157K | −$177K | — | -0.02 | −$46 | — | — | Aug 14 |
| Q1 2026 · Mar 31 | — | — | — | −$155K | −$175K | — | -0.02 | −$4K | — | — | May 20 |
| Q4 2025 · Dec 31derived | — | — | — | −$148K | −$169K | — | -0.03 | −$28K | — | — | Apr 15 |
| Q3 2025 · Sep 30 | — | — | — | −$144K | −$165K | — | -0.02 | −$22K | — | — | Nov 19 |
| Q2 2025 · Jun 30 | — | — | — | −$149K | −$172K | — | -0.02 | −$32K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | −$175K | −$181K | — | -0.03 | −$29K | — | — | May 20 |
| Q4 2024 · Dec 31derived | — | — | — | −$150K | −$153K | — | -0.02 | −$21K | — | — | Apr 15 |
| Q3 2024 · Sep 30 | — | — | — | −$186K | −$187K | — | -0.03 | −$13K | — | — | Nov 19 |
| Q2 2024 · Jun 30 | — | — | — | −$274K | −$294K | — | -0.04 | −$116K | — | — | Aug 19 |
| Q1 2024 · Mar 31 | — | — | — | −$269K | −$288K | — | -0.04 | −$91K | — | — | May 20 |
| Q4 2023 · Dec 31derived | — | — | — | −$276K | −$296K | — | -0.04 | −$97K | — | — | Apr 15 |
| Q3 2023 · Sep 30 | — | — | — | −$312K | −$333K | — | -0.05 | −$110K | — | — | Nov 19 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$616K | −$688K | — | -0.10 | −$111K | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$880K | −$922K | — | -0.13 | −$241K | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$1.4M | −$1M | — | -0.14 | −$497K | — | — | — | — |
| FY2022 · to Dec 31 | — | — | −$2.6M | −$2.4M | — | -0.33 | −$690K | — | — | — | — |
| FY2021 · to Dec 31 | — | — | −$3.5M | −$3.7M | — | -0.55 | −$679K | — | — | — | — |
| FY2020 · to May 31 | — | — | — | −$1.1M | — | 0.00 | −$987K | — | — | — | — |
Every number comes from Mosaic ImmunoEngineering Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.